APPLICATIONS PUBLISHED 12 JANUARY 2005
Published: 3-Jan-2006
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Combination therapy using trefoil peptides
The General Hospital Corp 1494530*
Fungicidal mixtures based on benzamidoxime derivatives and azoles
BASF 1494531*
Fungicidal mixtures based on benzamidoxime derivatives and a strobilurin derivative
BASF 1494532*
Farnesoid X-activated receptor agonists
The University of Chicago 1494533*
Compsns and minimally invasive methods for treating incomplete tissue repair
Mishra, Allan 1494535*
Oil body associated protein compsns and methods of use thereof for reducing the risk of cardiovascular disease
Monsanto Technology 1494536*
Process and plant for evaporative concentration and crystallizationof a viscous lactose-containing aqueous liquid
Niro 1494538*
Bioadhesive drug selivery system
Drugtech 1494630*
Adherent N,O-carboxymethylchitosan drug delivery devices for moist tissue and methods of their use
Chitogenics 1494633*
Controlled delivery patch of active ingredient
Salvora 1494634*
Aminophenylbenzothiazole compounds
Ciba Speciality Chemicals 1494641*
Dry powder compsns
Glaxo Group 1494644*
Method of treating mucus hypersecretion
Boehringer Ingelheim 1494645*
Intravaginal matrix drug delivery devices
Galen (Chemicals) 1494646*
Process for preparation of a sterile suspension of corticosteroid particles for the administration by inhalation
Chiesi Farmaceutici 1494647*
Powder formulation suitable for inhalation
Boehringer Ingelheim 1494648*
Nanoparticulate megesterol formulation
Elan Pharmaceutical 1494649*
Pharmaceutical formulation comprising melatonin
Neurim Pharmaceuticals 1494650*
Preservation of bioactive material by freeze-dried foam
Medimmune Vaccines 1494651*
Excipient for usein dry powder inhalation preparations
Campina Nederland Holding 1494652*
Sustained release pharmaceutical prepartations and methods for producing the same
Pliva 1494653*
Palatable chewable tablet
Pfizer Products 1494654*
Agent for producing a sensation of satiety and for weight loss
Briesel, Guenther 1494655*
Analgesic oral compsn with controlled release of an opioid
Zentiva 1494656*
Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases
Puleva Biotech 1494658*
Pharmaceutical compsn comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
Critical Therapeutics 1494659*
compsn and method for controlling spore-producing fungi and bacteria
Von Krosigk, James; Peterson, Thomas 1494660*
PTX3 gene expression suppressing method
Kowa; Nissan Chemical Industries 1494661*
TNP-470 polymer conjugates and use thereof
Children's Medical Centre Corp 1494662*
Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss
SmithKline Beecham 1494663*
Combinations of COX-2 inhibitors and other agents for the treatment of Parkinson's disease
Pharmacia 1494664*
Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
The Board of Trustees of The Leland Stanford Junior University, Office of Technology Licensing 1494665*
Orally deliverable pharmaceutical compsn comprising an active compound having an aminosulfonyl group (COX-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant
Pharmacia 1494666*
Imidazole compounds as anti-inflammatory and analgesic agents
Pfizer Japan 1494667*
Use of benzimidazole analogues in the treatment of cell proliferation
Avanir Phatamaceuticals; Sircar, Jagadish 1494668*
Medicament for preventing and/or treating chronic rejection
Fujisawa Pharmaceutical 1494669*
Medicine for treating cancer
Kowa 1494670*
1-(4-piperidinyl)benzimidazolones as histamine H3 antagonists
Schering 1494671*
Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
Abbott Laboratories 1494672*
Compounds having unique CB1 receptor binding selectivity and methods for their production and use
Research Triangle Institute 1494673*
Carboximide derivatives as useful uro-selective alpha-1A adrenoceptor blockers
Ranbaxy Laboratories 1494674*
Inhibitors of AKT activity
Merck 1494675*
Fused quinoxaline derivatives as inhibitors of AKT activity
Merck 1494676*
Use of methylene blue and related compounds to prevent or reverse an exaggerated haemodynamic reaction
Institut de Cardiologie de Montreal 1494677*
Method of hormonal therapy
Barr Laboratories 1494678*
Step-down oestrogen therapy
Barr Laboratories 1494679*
Use of carbon-2-modified vitamin D analogues to induce the formation of new bone
Wisconsin Alumni Research Foundation 1494680*
Methods of simultaneously treating ocular rosacea and acne rosacea
Collagenex Pharmaceuticals 1494681*
Method for inhibiting bone resorption with an alendronate and vitamin D formulation
Merck 1494683*
Use of DSRNAS in strategic therapeutic intervention of highly active antiretroviral therapy
Hemispherx Biopharma 1494684*
Method of treating arrhythmias comprising administration of an A1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
CV Therapeutics 1494685*
Oral rehydration compsn
Cera Products 1494686*
Immunomodulatory polymeric antigens for treating immunotherapy
Eli Lilly 1494687*
Use of topical compsns for the control of microbial diseases of the nail
Conve 1494688*
Process for harvesting organic compounds from plant roots
Pharmaleads 1494689*
Cochleates made with purified soy phosphatidylserine
Biodelivery Sciences International 1494690*
Treatment of dieases involving defective gap junctional communication
Mars 1494691*
Topical pharmaceutical compsns comprising proanthocyanidins for the treatment of dermatitis
Sinclair Pharmaceuticals 1494692*
Cripto-specific antibodies
Biogen 1494693*
Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging
Peptor 1494694*
Plasma protein-binding ligands
The American National Red Cross 1494695*
Treatment of lung disorder
GTC Therapeutics 1494696*
Monomeric and dimeric fluorescent protein variants and methods for making same
The Regents of the University of California 1494697*
Compsns and methods for treating and preventing necrosis
Bun-Gurion University of the Negev 1494698*
Method for inhibiting vascular hyperpermeability
Children's Medical Centre Corp 1494699*
Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
Cytovia 1494700*
Immuniosuppressant compounds, methods and uses related thereto
GPC Biotech 1494701*
Compsn for stimulating de novo bone induction
University of Witwatersrand, Bone Research Unit 1494702*
Chemokines mutants having improved oral bioavailability
Applied Research Systems 1494703*
GLP-1 agonist and cardiovascular complications
Novo Nordisk 1494704*
A compsn and method for the killing of tumours
Commonwealth Scientific and Industrial Research Organisation 1494705*
Antimicrobial polymer conjugates
Biosynexus 1494706*
Synthetic peptides and DNA sequences for treatment of multiple sclerosis
Yeda Research and Development 1494707*
Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
Capua, Ilaria 1494708*
Methods for treating chronic obstructive pulmonary disease (COPD)
Abgenix; Pfizer 1494711*
Multiple sclerosis-related immunoglobulin derived proteins, compsns, methods and uses
Centocor 1494712*
Methods for treating tweak-related conditions
Biogen 1494713*
Human anti-OPGL neutralising antibodies as selective OPGL pathway inhibitors
Amgen 1494714*
FP receptor antagonists or PGF2 aplha antagonists for treating menorrhagia
Medical Research Council 1494715*
Use of substances for treating tumours
ProteoSys 1494716*
Use of resistin to treat haematopoetic disorders
Eli Lilly 1494717*
Combination of an agent that attenuates topoisomerase I activity and an agent that inhibits heat shock protein 90 for use in chemotherapy
The University of Liverpool 1494718*
Treatment methods for eotaxin mediated inflammatory conditions
Mercia Pharma 1494722*
